Clorox (NYSE:CLX) Releases FY 2027 Earnings Guidance

Clorox (NYSE:CLX) issued an update on its FY 2027 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.700-6.000 for the period, compared to the consensus estimate of 6.230. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.5 billion.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CLX shares. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Evercore restated an “underperform” rating and set a $98.00 target price on shares of Clorox in a report on Thursday, July 23rd. Wells Fargo & Company cut their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Royal Bank Of Canada reduced their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. Finally, JPMorgan Chase & Co. decreased their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research note on Thursday, July 16th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $101.00.

Clorox Stock Up 2.9%

NYSE:CLX traded up $2.72 during midday trading on Monday, reaching $98.25. 3,979,902 shares of the stock traded hands, compared to its average volume of 2,541,923. Clorox has a 12-month low of $84.70 and a 12-month high of $128.90. The business has a 50-day moving average of $95.51 and a two-hundred day moving average of $103.64. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market capitalization of $11.88 billion, a PE ratio of 15.95 and a beta of 0.54.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities analysts forecast that Clorox will post 5.52 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. This is a positive change from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. This represents a $5.00 annualized dividend and a yield of 5.1%. Clorox’s dividend payout ratio (DPR) is presently 80.52%.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.63% of the stock is currently owned by company insiders.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported quarterly adjusted EPS of $1.66, ahead of the $1.64 consensus estimate, while revenue of $1.95 billion exceeded expectations of $1.91 billion. Clorox earnings press release
• Positive Sentiment: Management projected fiscal 2027 revenue of approximately $7.6 billion to $7.7 billion, above the roughly $7.5 billion analyst consensus. The outlook reflects expected 13% to 14% sales growth, helped substantially by the GOJO acquisition.
• Positive Sentiment: Clorox declared a quarterly dividend of $1.25 per share, up from $1.24, supporting the stock’s income appeal with an indicated yield of about 5.2%.
• Neutral Sentiment: The company said it completed the GOJO acquisition in April and finished its U.S. enterprise-resource-planning implementation, important milestones that could support future execution but may require continued integration spending. Clorox reports fiscal 2026 results and fiscal 2027 outlook
• Negative Sentiment: Fiscal 2026 remained weak: full-year sales declined 5% to $6.72 billion and diluted EPS fell 26% to $4.81. Fourth-quarter sales decreased 2% year over year, while reported diluted EPS dropped 50% to $1.34, reflecting cost pressures. Clorox fourth-quarter sales report
• Negative Sentiment: Fiscal 2027 EPS guidance of $5.70 to $6.00 is below the $6.23 consensus estimate. Clorox also warned that inflation and consumers’ increasing focus on value are creating a difficult operating environment, keeping pressure on margins and demand. Clorox projects a difficult fiscal 2027

Hedge Funds Weigh In On Clorox

Several hedge funds have recently modified their holdings of the stock. Haverford Trust Co boosted its stake in Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after purchasing an additional 84 shares in the last quarter. Golden State Wealth Management LLC increased its stake in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after purchasing an additional 100 shares in the last quarter. Johnson Financial Group Inc. raised its holdings in shares of Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after buying an additional 109 shares during the last quarter. State of Wyoming raised its holdings in shares of Clorox by 4.7% in the second quarter. State of Wyoming now owns 2,540 shares of the company’s stock worth $305,000 after buying an additional 113 shares during the last quarter. Finally, Compound Planning Inc. lifted its stake in shares of Clorox by 6.5% during the fourth quarter. Compound Planning Inc. now owns 2,123 shares of the company’s stock worth $214,000 after buying an additional 129 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.